ExpreS2ion Biotechnologies
ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Horsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.

ExpreS2ion is part of the PREVENT-nCoV consortium comprising AdaptVac (a joint-venture between ExpreS2ion Biotechnologies and the University of Copenhagen spin-out NextGen Vaccines), Leiden University Medical Center, Institute for Tropical Medicine Tübingen, the Department of Immunology and Microbiology (ISIM) at the University of Copenhagen, and the Laboratory of Virology at Wageningen University and Research. In March 2020 the consortium was awarded an EU Horizon 2020 grant of €2.7million for the development of a COVID-19 vaccine candidate, of which ExpreS2ion was funded with €0.88million.
Q35
Danish
LOC
Q134808
vaccine
Concept
Q1427096
immunotherapy
Concept
Q20835
Horsholm
LOC
Q35
Denmark
LOC
Q4346290
Nasdaq First North
MEDIA
Q34
Sweden
LOC
Q186285
University of Copenhagen
ORG
Q2406409
Leiden University Medical Center
PER
Q31839349
Institute for Tropical Medicine Tübingen
UNK
Q422208
Wageningen University and Research
LOC
Q1438124
Horizon 2020
MEDIA
Q87719492
COVID-19 vaccine
Concept
Q96377541
ExpreS2ion Biotechnologies
UNK
Q96377541
ExpreS2ion Biotechnologies
UNK
2020-03-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
March 2020
DATE
2020-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2020
DATE
+2^^http://www.w3.org/2001/XMLSchema#decimal
2
NUMBER
+2^^http://www.w3.org/2001/XMLSchema#decimal
2
NUMBER
+2^^http://www.w3.org/2001/XMLSchema#decimal
2
NUMBER
+2.7^^http://www.w3.org/2001/XMLSchema#decimal
2.7
NUMBER
-19^^http://www.w3.org/2001/XMLSchema#decimal
-19
NUMBER
+2^^http://www.w3.org/2001/XMLSchema#decimal
2
NUMBER
+0.88^^http://www.w3.org/2001/XMLSchema#decimal
0.88
NUMBER
country
country